Journal of Sports and Biomotor Sciences

Journal of Sports and Biomotor Sciences

The effect of high intensity interval training (HIIT) with portulaca Oleracea supplementation on serum levels of liver enzyme in rats with non-alcoholic fatty live disease

Authors
Abstract
Introduction and purpose: The aim of presenet study was survey the Effect of Portulaca Oleracea Supplementation with High Intensity Interval Training (HIIT) on Serum Levels of Liver Enzyme in Rats with Non Alcoholic Fatty Liver (NAFLD).
Materials and Methods: For this purpose, 25 male Wistar rats randomly divided into 5 groups: healthy control (n = 5), fatty liver control (n = 5), supplement. (N = 5), HIIT (n = 5) and HIIT+ supplement (n = 5). To induce NAFLD, rats were fed a high-fat diet for 12 weeks. Portulaca oleracea supplement at a dose of 400 mg/kg was given to the respective groups. The HIIT training protocol was performed for 8 weeks, 5 sessions per week with 90% of maximum speed. Plasma ALT, AST and ALP levels were measured by photometric methods. For data analysis, one-way ANOVA and post hoc Tukey tests were performed at a significance level of P˂0.05.
Results: AST levels in HIIT training grouP (P=0.007) and supplement+HIIT (P=0.005) was significantly lower than the control grouP. However, despite the decrease in plasma AST levels in the supplement grouP compared to the fatty liver control grouP, this difference was not statistically significant (P=0.052). ALT level in the supplement grouP (P=0.038), HIIT (P=0.047) and HIIT+supplement (P=0.021) was significantly lower than the fatty liver control grouP. There was no significant difference between serum ALP levels of study groups after 8 weeks of HIIT training and portulaca oleracea supplementation (P=0.657).
Discussion and Conclusion: Base on these results probably Portulaca Oleracea Supplementation with HIIT can be used as a complementary and non-pharmacological therapy in people with NAFLD.
Key words: High intensity interval training (HIIT), Alanine Aminotransferase, Aspartate Aminotransferase, Portulaca oleracea Supplement, Non-Alcoholic Fatty Liver
Keywords

. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-89. 2. Tutunchi H, Saghafi‐Asl M, Ostadrahimi A. A systematic review of the effects of oleoylethanolamide, a high‐affinity endogenous ligand of PPAR‐α, on the management and prevention of obesity. Clin Exp Pharmacol Physiol. 2020;47(4):543-52. 3. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease Role Of Stearoyl-Coa Desaturase. J Biol Chem. 2009;284(9):5637-44. 4. Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obes Metab. 2021;23(5):1069-83. 5. Zhang Y, Zhou G, Chen Z, Guan W, Zhang J, Bi M, et al. Si-Wu-Tang alleviates nonalcoholic fatty liver disease via blocking TLR4-JNK and caspase-8-GSDMD signaling pathways. Evid based Complement Alternat Med. 2020;2020. 6. Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19(7):994-1003. 7. Perdomo CM, Frühbeck G, Escalada J. Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients. 2019;11(3):677. 8. Tutunchi H, Ostadrahimi A, Saghafi‐Asl M, Maleki V. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obes Rev. 2019;20(7):1057-69. 9. Wong VW-S, Chan RS-M, Wong GL-H, Cheung BH-K, Chu WC-W, Yeung DK-W, et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013;59(3):536-42. 10. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56(1):255-66. 11. Gibala MJ, Little JP, MacDonald MJ, Hawley JA. Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. J Physiol. 2012;590(5):1077-84. 12. Hottenrott K, Ludyga S, Schulze S. Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners. J Sports Sci Med. 2012;11(3):483. 13. Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr. 2015;28(1):39-44. 14. Hsu W-F, Sheen L-Y, Lin H-J, Chang H-H. A review of Western and traditional Chinese medical approaches to managing nonalcoholic fatty liver disease. Evid Based Complement Alternat Med. 2016;2016:6491420. 15. Zarei A, Changizi

  • Receive Date 23 November 2022
  • Revise Date 27 February 2023